Globus Medical (GMED) Capital Expenditures Growth (3y) (2014 - 2026)
Globus Medical (GMED) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | 2.15% |
| 10 | Globus Medical | 10.61 Bn | 9.98 Bn | 525.79 Mn | 82.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.73% |
| Dec 31, 2025 | 36.06% |
| Sep 30, 2025 | 106.18% |
| Jun 30, 2025 | -43.48% |
| Mar 31, 2025 | 21.82% |
| Dec 31, 2024 | -93.31% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | 211.80% |
| Mar 31, 2024 | 121.75% |
| Dec 31, 2023 | 17.62% |
| Sep 30, 2023 | -20.86% |
| Jun 30, 2023 | 215.91% |
| Mar 31, 2023 | 7.09% |
| Dec 31, 2022 | 33.17% |
| Sep 30, 2022 | -0.22% |
| Jun 30, 2022 | 17.24% |
| Mar 31, 2022 | -10.82% |
| Dec 31, 2021 | 32.83% |
| Sep 30, 2021 | 3.74% |
| Jun 30, 2021 | -60.42% |